Publicações seleccionadas

By admin on Novembro 3, 2010

  • Da Silva JAP, Bijlsma JWJ. Optimizing glucocorticoid therapy in rheumatoid arthritis. In Neuroendocrine mechanisms in rheumatic diseases, Ed. A. Masi. Rheumatic Diseases Clinics of North America, 2000; 26:4: 859-880.
  • Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, JAP da Silva, PLCM van Riel. Influence of sex, age and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001; 28: 1809-16.
  • Buttgereit F, Da Silva J A P, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimes: current questions and tentative answers in Rheumatology. Ann Rheum Dis 2002; 61: 718-722.
  • Silva C, Inês LS, Nour D, Straub RH, Da Silva, JAP. Differential male and female adrenal cortical steroid hormone and cortisol responses to nlterleukin-6 in humans. In Neuroendocrine Immune Basis of the Rheumatic Diseases II, Cutolo M, Bijlsma JWJ, Lahita RG, e col. Eds. Annals of the New York Academy of Sciences, 2002; Vol 966, pp 68-72.
  • Da Silva JAP. Relationships between glucocorticoids and gonadal steroids in rheumatoid arthritis. In Neuroendocrine Immune Basis of the Rheumatic Diseases II, Cutolo M, Bijlsma JWJ, Lahita RG, e col. Eds. Annals of the New York Academy of Sciences, 2002; Vol 966, pp 158-165.
  • Bijlsma JW, Saag KG, Buttgereit F, da Silva JAP. Developments in glucocorticoid therapy. Rheumatic Diseases Clinics of North America 2005 Feb; 31(1): 1-17. F
  • Buttgereit, KG Saag, M Cutolo, JAP da Silva, JWJ Bijlsma. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scandinavian Journal of Rheumatology 2005;34:1–8.
  • Inês LPBS, Da Silva JAP. Soft tissue injections. In Practical Procedures in Rheumatology. Guest Editors: J.A.P. Da Silva, M Doherty, J.W.J. Bijlsma. Clinical Rheumatology. Best Practice & Research 2005; 19(3): 503-527.
  • Da Silva JAP, et al. Low dose glucocorticoid therapy in rheumatoid arthritis. A review on safety: published evidence and prospective trial data. Ann Rheum Dis 2006;65;285-293.
  • Kauppi MJ, Barcelos A, Da Silva JAP. Problem of the month: cervical complications of rheumatoid arthritis. Ann Rheum Dis 2005; 64: 355-358.
  • Teles J, Fonseca JE, Da Silva JAP. Pivotal roles of  glucocorticoids in the pathogenesis and treatment of inflammatory rheumatic diseases. Acta Reumatológica Portuguesa 2005; 30(1): 27-33.
  • Da Silva JAP. Neuro-imuno-endocrinologia: o homem como um todo. (Editorial) Acta Reumatológica Portuguesa 2005;30:295-297.
  • Ralston SH, Uitterlinden AG,  Brandi ML  et al..  Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: The GENOMOS Study. PLoS Med 2006;3(4): e90.
  • Janele D, Lang T, Capellino S, Cutolo M, Da Silva JAP, Straub RH. Effects of testosterone, 17beta-estradiol, and downstream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol. Ann N Y Acad Sci.  2006 Jun;1069:168-82.
  • Uitterlinden AG, Ralston SH, Brandi ML et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006 Aug 15;145(4):255-64.
  • Da Silva JAP, Jacobs JW, Bijlsma JW. Revisiting the toxicity of low-dose glucocorticoids: risks and fears. Ann N Y Acad Sci. 2006 Jun;1069:275-88.
  • Cardoso R, Gonçalo M, Tellechea O, maia R, Borges C, Da Silva JAP, Figueiredo A.  Livedoid vasculopathy and hypercoagulability in a patient with primary Sjogren’s syndrome. International Journal of Dermatology 2007,46:431-4.
  • Hoes JN, Jacobs JW, Boers M, et al EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis. 2007 Dec;66(12):1560-7.
  • Gaspar MF, Mota Pinto A, Carrilho E, Da Silva JAP. Médicos do futuro. A selecção dos alunos de Medicina em Portugal e os desafios do médico do séc. XXI. Revista da Ordem dos Médicos 2007, Ano 23 – Nº81: 40-47.
  • Mota Pinto A, Gaspar MF, Conceição HCF, Da Silva JAP. Porque a competência conta: O reforço do papel da avaliação dos docentes na estratégia de desenvolvimento de uma faculdade clássica de medicina. Revista Lusófona de Ciências e Tecnologias da Saúde 2007, Ano 4 – Nº1: 9-21.
  • Kaptoge S, da Silva JAP, et al.  Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study.  Bone. 2008 Aug;43(2):332-9.
  • Carville SF, Arendt-Nielsen S, Bliddal H, et al.  EULAR. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008 Apr;67(4):536-41.
  • Karen Lisbeth Faarvang KL, Cátia Duarte C, Da Silva JAP. Medical clues for the diagnosis of vasculitis: a diagnostic strategy. Acta Reum Port 2008; 33 (Supl): 66-70.
  • Machado P, da Silva JAP. Performance of decision algorithms for the identification of low bone mineral density in Portuguese postmenopausal women. Acta Reumatol Port. 2008 Jul-Sep;33(3):314-28.
  • Da Silva JAP, Faarvang KL, Bandilla K, Woolf AD; UEMS Section and Board of Rheumatology. UEMS charter on the training of rheumatologists in Europe. Ann Rheum Dis. 2008 Apr;67(4):555-8.
  • Saavedra MJ, Ambrósio C, Malcata A, Matucci-Cerinic M, Da Silva JAP. Exuberant calcinosis and acroosteolysis. A diagnostic challenge. Clin Exp Rheum 2009; 27 (Suppl.54);S55-58.
  • Faarvang KL, da Silva JAP. Competencies in rheumatology: a European framework. Best Pract Res Clin Rheumatol. 2009 Apr;23(2):145-60.
  • Jacobs JWG,  Da Silva JAP, Armbrecht G, Bijlsma JWJ. Prediction of vertebral fracture is specific for  gender and site of bone mineral density measurement. J Rheumatol  2010; 37: 149-54.
  • Machado P, Coutinho M, da Silva JA. Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men. Osteoporos Int. 2010 Jun;21(6):977-83.
  • van der Goes MC, J W G Jacobs, et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.  Ann Rheum Dis 2010;69:1015-1021.
  • Da Silva JAP et al. Patients’ and physicians’ priorities for improvement. The case of rheumatic diseases Acta Reumatol Port. 2010;35:192-199.
  • Henriques A, Inês L,  et al.  Frequency and functional activity of th17, tc17 and other t-cell subsets in systemic lupus eruthemathosus. Cellular Immunology 2010;264:97-103.
  • Raposo B, Rodrigues-Santos P, et al Monoclonal anti-CD8 therapy induces disease amelioration in the K/BxN mouse model of spontaneous chronic polyarthritis. Arthritis & Rheumatism October 2010;62: 2953–2962.
  • Van der Goes MC, Jacobs JWG, Boers M, et al. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis 2010;69:1913–1919
  • Ramiro S, Machado P, Singh JA, Landewé RB, Da Silva JAP. Applying science in practice: the optimization of biological therapy in rheumatoid arthritis. Arthritis Research & Therapy 2010, 12:220-24.

Os comentários estão fechados.